These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27229662)

  • 1. In vivo target bio-imaging of Alzheimer's disease by fluorescent zinc oxide nanoclusters.
    Lai L; Zhao C; Su M; Li X; Liu X; Jiang H; Amatore C; Wang X
    Biomater Sci; 2016 Jul; 4(7):1085-91. PubMed ID: 27229662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Biosynthesized Zinc and Iron Oxide Nanoclusters for High Spatiotemporal Dual-Modality Bioimaging of Alzheimer's Disease.
    Lai L; Jiang X; Han S; Zhao C; Du T; Rehman FU; Zheng Y; Li X; Liu X; Jiang H; Wang X
    Langmuir; 2017 Sep; 33(36):9018-9024. PubMed ID: 28806518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo characterization of several functionalized ultrasmall particles of iron oxide, vectorized against amyloid plaques and potentially able to cross the blood-brain barrier: toward earlier diagnosis of Alzheimer's disease by molecular imaging.
    Ansciaux E; Burtea C; Laurent S; Crombez D; Nonclercq D; Vander Elst L; Muller RN
    Contrast Media Mol Imaging; 2015; 10(3):211-24. PubMed ID: 25284012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The application of ZnO luminescent nanoparticles in labeling mice.
    Pan ZY; Liang J; Zheng ZZ; Wang HH; Xiong HM
    Contrast Media Mol Imaging; 2011; 6(4):328-30. PubMed ID: 21861292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age- and Brain Region-Specific Changes of Glucose Metabolic Disorder, Learning, and Memory Dysfunction in Early Alzheimer's Disease Assessed in APP/PS1 Transgenic Mice Using
    Li XY; Men WW; Zhu H; Lei JF; Zuo FX; Wang ZJ; Zhu ZH; Bao XJ; Wang RZ
    Int J Mol Sci; 2016 Oct; 17(10):. PubMed ID: 27763550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Formation of zinc-containing nanoparticles from Zn²⁺ ions in cell culture media: implications for the nanotoxicology of ZnO.
    Turney TW; Duriska MB; Jayaratne V; Elbaz A; O'Keefe SJ; Hastings AS; Piva TJ; Wright PF; Feltis BN
    Chem Res Toxicol; 2012 Oct; 25(10):2057-66. PubMed ID: 22978249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
    Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
    Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Cyclooxygenase-1 in Activated Microglia During Amyloid Plaque Progression: PET Studies in Alzheimer's Disease Model Mice.
    Shukuri M; Mawatari A; Ohno M; Suzuki M; Doi H; Watanabe Y; Onoe H
    J Nucl Med; 2016 Feb; 57(2):291-6. PubMed ID: 26585055
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intranasal nanoparticles of basic fibroblast growth factor for brain delivery to treat Alzheimer's disease.
    Zhang C; Chen J; Feng C; Shao X; Liu Q; Zhang Q; Pang Z; Jiang X
    Int J Pharm; 2014 Jan; 461(1-2):192-202. PubMed ID: 24300213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The potential use of H102 peptide-loaded dual-functional nanoparticles in the treatment of Alzheimer's disease.
    Zhang C; Zheng X; Wan X; Shao X; Liu Q; Zhang Z; Zhang Q
    J Control Release; 2014 Oct; 192():317-24. PubMed ID: 25102404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel biocompatible composite (Chitosan-zinc oxide nanoparticle): preparation, characterization and dye adsorption properties.
    Salehi R; Arami M; Mahmoodi NM; Bahrami H; Khorramfar S
    Colloids Surf B Biointerfaces; 2010 Oct; 80(1):86-93. PubMed ID: 20566273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinoline-n-butylcyanoacrylate-based nanoparticles for brain targeting for the diagnosis of Alzheimer's disease.
    Kulkarni PV; Roney CA; Antich PP; Bonte FJ; Raghu AV; Aminabhavi TM
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2010; 2(1):35-47. PubMed ID: 20049829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poly(n-butylcyanoacrylate) nanoparticles coated with polysorbate 80 for the targeted delivery of rivastigmine into the brain to treat Alzheimer's disease.
    Wilson B; Samanta MK; Santhi K; Kumar KP; Paramakrishnan N; Suresh B
    Brain Res; 2008 Mar; 1200():159-68. PubMed ID: 18291351
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blood-brain barrier P-glycoprotein function in Alzheimer's disease.
    van Assema DM; Lubberink M; Bauer M; van der Flier WM; Schuit RC; Windhorst AD; Comans EF; Hoetjes NJ; Tolboom N; Langer O; Müller M; Scheltens P; Lammertsma AA; van Berckel BN
    Brain; 2012 Jan; 135(Pt 1):181-9. PubMed ID: 22120145
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Attenuated antiaggregation effects of magnetite nanoparticles in cerebrospinal fluid of people with Alzheimer's disease.
    Gažová Z; Antošová A; Krištofiková Z; Bartoš A; Ríčný J; Cechová L; Klaschka J; Rípová D
    Mol Biosyst; 2010 Nov; 6(11):2200-5. PubMed ID: 20721410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inulin as a novel biocompatible coating: evaluation of surface affinities toward CaHPO4, α-Fe2O3, ZnO, CaHPO4@ZnO and α-Fe2O3@ZnO nanoparticles.
    Santillán-Urquiza E; Arteaga-Cardona F; Hernandez-Herman E; Pacheco-García PF; González-Rodríguez R; Coffer JL; Mendoza-Alvarez ME; Vélez-Ruiz JF; Méndez-Rojas MA
    J Colloid Interface Sci; 2015 Dec; 460():339-48. PubMed ID: 26364076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model.
    Munoz L; Ralay Ranaivo H; Roy SM; Hu W; Craft JM; McNamara LK; Chico LW; Van Eldik LJ; Watterson DM
    J Neuroinflammation; 2007 Sep; 4():21. PubMed ID: 17784957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The toxicology of ion-shedding zinc oxide nanoparticles.
    Liu J; Feng X; Wei L; Chen L; Song B; Shao L
    Crit Rev Toxicol; 2016; 46(4):348-84. PubMed ID: 26963861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative therapy of Alzheimer's disease via supplementation with choline acetyltransferase.
    Fu AL; Li Q; Dong ZH; Huang SJ; Wang YX; Sun MJ
    Neurosci Lett; 2004 Sep; 368(3):258-62. PubMed ID: 15364407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin-conjugated magnetic nanoparticles for detecting amyloid plaques in Alzheimer's disease mice using magnetic resonance imaging (MRI).
    Cheng KK; Chan PS; Fan S; Kwan SM; Yeung KL; Wáng YX; Chow AH; Wu EX; Baum L
    Biomaterials; 2015 Mar; 44():155-72. PubMed ID: 25617135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.